ArticleProceedings of the National Academy of Sciences of the United States of America2017

Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.

Haruka Okamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.